301 related articles for article (PubMed ID: 35250876)
1. Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH.
Chen M; Miao H; Liang H; Ke X; Yang H; Gong F; Wang L; Duan L; Chen S; Pan H; Zhu H
Front Endocrinol (Lausanne); 2022; 13():820001. PubMed ID: 35250876
[TBL] [Abstract][Full Text] [Related]
2. Familial Short Stature-A Novel Phenotype of Growth Plate Collagenopathies.
Plachy L; Dusatkova P; Maratova K; Petruzelkova L; Elblova L; Kolouskova S; Snajderova M; Obermannova B; Zemkova D; Sumnik Z; Lebl J; Pruhova S
J Clin Endocrinol Metab; 2021 May; 106(6):1742-1749. PubMed ID: 33570564
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Short-Stature Patients With an NPR2 Mutation and the Therapeutic Response to rhGH.
Ke X; Liang H; Miao H; Yang H; Wang L; Gong F; Pan H; Zhu H
J Clin Endocrinol Metab; 2021 Jan; 106(2):431-441. PubMed ID: 33205215
[TBL] [Abstract][Full Text] [Related]
4. IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy.
Vasques GA; Funari MFA; Ferreira FM; Aza-Carmona M; Sentchordi-Montané L; Barraza-García J; Lerario AM; Yamamoto GL; Naslavsky MS; Duarte YAO; Bertola DR; Heath KE; Jorge AAL
J Clin Endocrinol Metab; 2018 Feb; 103(2):604-614. PubMed ID: 29155992
[TBL] [Abstract][Full Text] [Related]
5. NPR2 Variants Are Frequent among Children with Familiar Short Stature and Respond Well to Growth Hormone Therapy.
Plachy L; Dusatkova P; Maratova K; Petruzelkova L; Zemkova D; Elblova L; Kucerova P; Toni L; Kolouskova S; Snajderova M; Sumnik Z; Lebl J; Pruhova S
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31990356
[TBL] [Abstract][Full Text] [Related]
6. Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH.
Chen H; Zhang S; Sun Y; Chen J; Yuan K; Zhang Y; Yang X; Lin X; Chen R
Orphanet J Rare Dis; 2023 Jul; 18(1):221. PubMed ID: 37501190
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis is an important indicator for response to growth hormone therapy in children with short stature.
Zhao Q; Zhang M; Li Y; Zhang C; Zhang Y; Shao Q; Wei W; Yang W; Ban B
Clin Chim Acta; 2024 Feb; 554():117779. PubMed ID: 38220134
[TBL] [Abstract][Full Text] [Related]
8. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.
Vasques GA; Hisado-Oliva A; Funari MF; Lerario AM; Quedas EP; Solberg P; Heath KE; Jorge AA
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):111-116. PubMed ID: 27941173
[TBL] [Abstract][Full Text] [Related]
9. Growth-Promoting Therapies May Be Useful In Short Stature Patients With Nonspecific Skeletal Abnormalities Caused By Acan Heterozygous Mutations: Six Chinese Cases And Literature Review.
Liang H; Miao H; Pan H; Yang H; Gong F; Duan L; Chen S; Wang L; Zhu H
Endocr Pract; 2020 Nov; 26(11):1255-1268. PubMed ID: 33471655
[TBL] [Abstract][Full Text] [Related]
10. Short stature and growth hormone use in pediatric hemodialysis patients.
Gorman G; Fivush B; Frankenfield D; Warady B; Watkins S; Brem A; Neu A
Pediatr Nephrol; 2005 Dec; 20(12):1794-800. PubMed ID: 16133065
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis and growth hormone response in patients with syndromic short stature.
Sun H; Li N; Wan N
BMC Med Genomics; 2021 Nov; 14(1):261. PubMed ID: 34740356
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panel.
Yang L; Zhang C; Wang W; Wang J; Xiao Y; Lu W; Ma X; Chen L; Ni J; Wang D; Shi J; Dong Z
BMC Med Genet; 2018 Dec; 19(1):212. PubMed ID: 30541462
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response.
Muthuvel G; Dauber A; Alexandrou E; Tyzinski L; Andrew M; Hwa V; Backeljauw P
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2103-e2109. PubMed ID: 34922359
[TBL] [Abstract][Full Text] [Related]
15. The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review.
Chen M; Ke X; Liang H; Gong F; Yang H; Wang L; Duan L; Pan H; Cao D; Zhu H
Mol Genet Genomic Med; 2021 Dec; 9(12):e1842. PubMed ID: 34747577
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.
Gkourogianni A; Andrew M; Tyzinski L; Crocker M; Douglas J; Dunbar N; Fairchild J; Funari MF; Heath KE; Jorge AA; Kurtzman T; LaFranchi S; Lalani S; Lebl J; Lin Y; Los E; Newbern D; Nowak C; Olson M; Popovic J; Pruhová Š; Elblova L; Quintos JB; Segerlund E; Sentchordi L; Shinawi M; Stattin EL; Swartz J; Angel AG; Cuéllar SD; Hosono H; Sanchez-Lara PA; Hwa V; Baron J; Nilsson O; Dauber A
J Clin Endocrinol Metab; 2017 Feb; 102(2):460-469. PubMed ID: 27870580
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature.
Hattori A; Katoh-Fukui Y; Nakamura A; Matsubara K; Kamimaki T; Tanaka H; Dateki S; Adachi M; Muroya K; Yoshida S; Ida S; Mitani M; Nagasaki K; Ogata T; Suzuki E; Hata K; Nakabayashi K; Matsubara Y; Narumi S; Tanaka T; Fukami M
Endocr J; 2017 Oct; 64(10):947-954. PubMed ID: 28768959
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
[TBL] [Abstract][Full Text] [Related]
19. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
